Autore	Salgia Ravi
Pubbl/distr/stampa	Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica	1 online resource (250 p.)
Soggetto topico	Medicine and Nursing
Soggetto non controllato	academic and community oncology academic cancer center actionable mutations adjuvant chemotherapy bladder cancer breast cancer cancer care plans cancer center cancer clinical trials cancer genetics cancer genomics cancer prevention clinical research clinical trials colorectal cancer community community oncology community practice concurrent chemoradiation therapy COVID-19 driver mutations Early Recovery After Surgery (ERAS) epithelial ovarian cancer ethnicity fast-and-frugal trees feeding tube dependency frontline treatment genetics counseling geriatric oncology HER2-directed therapy human papillomavirus immunotherapy integrated cancer care low-dose CT scans lung cancer lung cancer screening maintenance therapy minorities n/a national guidelines for screening and prevention next-generation sequencing non-small cell lung cancer older adults oncology medical home oncology pathways oropharyngeal cancer PARP inhibitor personalized medicine pharmaceutical aids to smoking cessation precisian medicine precision medicine race receptor tyrosine kinases recruitment renal cell carcinoma research small cell lung cancer smoking cessation supportive care pathways surgical debulking surgical pathways team medicine team science team-based care team-based medicine testing rates tobacco control translational research urothelial carcinoma value-based cancer care value-based care
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Record Nr.	UNINA-9910557124403321

Autore	Cheung Kwok-Leung
Pubbl/distr/stampa	MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica	1 online resource (264 p.)
Soggetto topico	Medicine and Nursing
Soggetto non controllato	abemaciclib advanced breast cancer anthracycline resistance antihormone therapy APOBEC3B aromatase inhibitors ATM basal-like breast cancer biomarker BRCA breast cancer Breast Cancer breast cancer survivors breast-conserving therapy cancer treatment cell-free DNA CHEK2 chemotherapy circulating tumor cells cMet colorectal cancer comparative effectiveness contralateral breast cancer contralateral prophylactic mastectomy cyclin E disease-free survival ductal carcinoma in situ Endocrine therapy ERCC1 exercise characteristics family history fulvestrant gene expression geriatric oncology HDAC5 inhibitors HER2 c-erbB2 HER2/neu histone deacetylase incidence infiltrating breast cancer invasive breast cancer lactate dehydrogenase lapatinib LDH liquid biopsy LKB1 LMK-235 lymph-node ratio mammography screening mastectomy metastatic metastatic breast cancer Metformin monitoring metastatic breast cancer mutation carriers n/a NCDB next-generation sequencing older patients Older women outcome overdiagnosis PALB2 palbociclib pertuzumab physical activity physical function PIK3CA prognosis radiotherapy relative survival ribociclib SEER serum biomarker social well-being Src kinase stage IV survival T-DM1 taxane sensitivity trastuzumab tumor biology young women zero-inflated Poisson regression model
ISBN	3-03928-759-1
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Record Nr.	UNINA-9910404084403321